How CBD and Metformin Are Revolutionizing Treatment for Autism-Related Behavioral Issues

New research highlights how cannabidiol and metformin can alleviate behavioral difficulties in mouse models of Fragile X and Phelan-McDermid syndromes.

These treatments have been shown to improve behavioral symptoms, with further research underway to explore their potential applications in humans.

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties. This is according to research that will be presented on June 26 at the Federation of European Neuroscience Societies (FENS) Forum 2024.[1]